Ashland Inc

ASH is in Stage 2 – Advancing with clear higher-highs and higher-lows supported by rising EMAs, but price is extended above the 9/21 EMA zone and tagged overbought. A Bullish Exhaustion candle at recent highs signals early fatigue. The medium-term bias remains bullish, yet entries should be deferred until a pullback into the rising 9/21 EMA area provides a structurally favorable entry.

• ↑Q2 2026 revenue reached $482M (+1% YoY), led by stable life sciences and personal care volumes
• ↑Adjusted EBITDA margin improved to ~20% in Q2, reflecting cost-saving initiatives
• ↓Q2 adjusted EBITDA fell 9% YoY to $98M, hindered by manufacturing disruptions